Samer Abdul Hay

Samer Abdul Hay

Mayo Clinic - Rochester / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1351581
Mayo Clinic College of Medicine and Science
person_outline Samer Abdul Hay's MOST POPULAR ARTICLES
1-) Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin toleranceSO Abdul-Hay, D Kang, M McBride, L Li, J Zhao, MA LeissringPloS one 6 (6), e20818, 20111332011
2-) Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulinMA Leissring, E Malito, S Hedouin, L Reinstatler, T Sahara, SO Abdul-Hay, ...PloS one 5 (5), e10504, 20101332010
3-) Identification of BACE2 as an avid ß-amyloid-degrading proteaseSO Abdul-Hay, T Sahara, M McBride, D Kang, MA LeissringMolecular neurodegeneration 7, 1-12, 2012832012
4-) ApoE variant p. V236E is associated with markedly reduced risk of Alzheimer’s diseaseCW Medway, S Abdul-Hay, T Mims, L Ma, G Bisceglio, F Zou, S Pankratz, ...Molecular neurodegeneration 9, 1-5, 2014772014
5-) Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivitySO Abdul-Hay, AL Lane, TR Caulfield, C Claussin, J Bertrand, A Masson, ...Journal of medicinal chemistry 56 (6), 2246-2255, 2013612013